Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma
Abstract
Background: Fatty acids and lipid mediator signaling play an important role in the pathogenesis of asthma, yet this area remains largely underexplored. The aims of this study were (i) to examine fatty acid levels and their metabolism in obese and nonobese asthma patients and (ii) to determine the functional effects of altered fatty acid metabolism in experimental models.Methods: Medium‐ and long‐chain fatty acid levels were quantified in serum from 161 human volunteers by LC/MS. Changes in stearoyl‐coenzyme A desaturase (SCD) expression and activity were evaluated in the ovalbumin (OVA) and house dust mite (HDM) murine models. Primary human bronchial epithelial cells from asthma patients and controls were evaluated for SCD expression and activity.Results: The serum desaturation index (an indirect measure of SCD) was significantly reduced in nonobese asthma patients and in the OVA murine model. SCD1 gene expression was significantly reduced within the lungs following OVA or HDM challenge. Inhibition of SCD in mice promoted airway hyper‐responsiveness. SCD1 expression was suppressed in bronchial epithelial cells from asthma patients. IL‐4 and IL‐13 reduced epithelial cell SCD1 expression. Inhibition of SCD reduced surfactant protein C expression and suppressed rhinovirus‐induced IP‐10 secretion, which was associated with increased viral titers.Conclusions: This is the first study to demonstrate decreased fatty acid desaturase activity in humans with asthma. Experimental models in mice and human epithelial cells suggest that inhibition of desaturase activity leads to airway hyper‐responsiveness and reduced antiviral defense. SCD may represent a new target for therapeutic intervention in asthma patients.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_154488, 310030_144219, 310030‐127356, 310030_144219)
- Narodowe Centrum Nauki (2011/01/B/NZ6/01872, 2012/04/M/NZ6/00355)
- GlaxoSmithKline
This publication has 37 references indexed in Scilit:
- An insight into the role of arachidonic acid derived lipid mediators in virus associated pathogenesis and malignanciesProstaglandins & Other Lipid Mediators, 2016
- What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trialsLipids in Health and Disease, 2016
- Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?Allergy, Asthma & Immunology Research, 2016
- Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human MacrophagesThe Journal of Immunology, 2015
- Fifty years of the asebia mouse: origins, insights and contemporary developmentsExperimental Dermatology, 2015
- Macrophages, Immunity, and Metabolic DiseaseImmunity, 2014
- Fatty acids, inflammation, and asthmaJournal of Allergy and Clinical Immunology, 2014
- Diet and InflammationNutrition in Clinical Practice, 2010
- Biochemical and physiological function of stearoyl-CoA desaturaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Skin-specific Deletion of Stearoyl-CoA Desaturase-1 Alters Skin Lipid Composition and Protects Mice from High Fat Diet-induced ObesityJournal of Biological Chemistry, 2009